A human centred innovative approach based on persona in hereditary angioedema.

IF 3.4 2区 医学 Q2 GENETICS & HEREDITY
Francesca Perego, Lorenza Chiara Zingale, Azzurra Cesoni Marcelli, Luca Ranucci, Lorenzo Rimoldi, Nurgul Nsanbayeva, Maria Rosaria Natale, Laura Adelaide Dalla Vecchia, Alessandra Gorini
{"title":"A human centred innovative approach based on persona in hereditary angioedema.","authors":"Francesca Perego, Lorenza Chiara Zingale, Azzurra Cesoni Marcelli, Luca Ranucci, Lorenzo Rimoldi, Nurgul Nsanbayeva, Maria Rosaria Natale, Laura Adelaide Dalla Vecchia, Alessandra Gorini","doi":"10.1186/s13023-024-03302-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hereditary Angioedema (HAE) due to C1-inhibitor deficiency (C1INH) is a rare condition, clinically characterised by recurrent swelling. The unpredictability of attacks affects the patients' quality of life (QoL). HAE patients and their families have vast unmet physical, psychological, and social needs. A human-centred design (HCD) approach to describing the needs of different user types is to utilise personas, a data-driven narrative tool for communicating user archetypes that capture the individuals' attitudes, goals, and behaviours. The aim of this study was to create and analyse personas based on HAE patients' and their caregivers' interviews. Semi-structured interviews were conducted through anthropological conversations with patients, patient-caregivers (double role of patient and caregiver), and non-affected caregivers. Qualitative and quantitative insights from analyses formed the basis to create personas.</p><p><strong>Results: </strong>We enrolled 17 subjects: 15 patients (6 of them were patient-caregivers) and 2 non-affected caregivers. The mean age of participants was 50.3 ± 14.4 years. Eight patients were on treatment with prophylactic therapy. The mean percentage score of Angioedema Quality of Life (AE-QoL) for HAE patients was 19.8 ± 12.0. Six personas were identified describing the participants' personal history, disease management, and needs: four personas referred to patients, one to patient-caregivers, and one non-affected caregiver personas were identified. Across patient personas, the most expressed needs were psychological support and better awareness amongst healthcare professionals. Caregivers, on their side, desired better information about the disease, including the latest therapies, and higher awareness within the community.</p><p><strong>Conclusion: </strong>A Human Centred Innovative Approach Based on Persona extends beyond the physical symptoms to encompass the psychological and social aspects of the individual's well-being also including the family in the evaluation.</p>","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316298/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orphanet Journal of Rare Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13023-024-03302-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hereditary Angioedema (HAE) due to C1-inhibitor deficiency (C1INH) is a rare condition, clinically characterised by recurrent swelling. The unpredictability of attacks affects the patients' quality of life (QoL). HAE patients and their families have vast unmet physical, psychological, and social needs. A human-centred design (HCD) approach to describing the needs of different user types is to utilise personas, a data-driven narrative tool for communicating user archetypes that capture the individuals' attitudes, goals, and behaviours. The aim of this study was to create and analyse personas based on HAE patients' and their caregivers' interviews. Semi-structured interviews were conducted through anthropological conversations with patients, patient-caregivers (double role of patient and caregiver), and non-affected caregivers. Qualitative and quantitative insights from analyses formed the basis to create personas.

Results: We enrolled 17 subjects: 15 patients (6 of them were patient-caregivers) and 2 non-affected caregivers. The mean age of participants was 50.3 ± 14.4 years. Eight patients were on treatment with prophylactic therapy. The mean percentage score of Angioedema Quality of Life (AE-QoL) for HAE patients was 19.8 ± 12.0. Six personas were identified describing the participants' personal history, disease management, and needs: four personas referred to patients, one to patient-caregivers, and one non-affected caregiver personas were identified. Across patient personas, the most expressed needs were psychological support and better awareness amongst healthcare professionals. Caregivers, on their side, desired better information about the disease, including the latest therapies, and higher awareness within the community.

Conclusion: A Human Centred Innovative Approach Based on Persona extends beyond the physical symptoms to encompass the psychological and social aspects of the individual's well-being also including the family in the evaluation.

在遗传性血管性水肿中采用基于角色的以人为本的创新方法。
背景:由 C1 抑制剂缺乏症(C1INH)引起的遗传性血管性水肿(HAE)是一种罕见疾病,临床特点是反复肿胀。发作的不可预测性影响了患者的生活质量(QoL)。HAE 患者及其家属有大量的生理、心理和社会需求没有得到满足。以人为本的设计(HCD)方法是利用 "角色 "来描述不同用户类型的需求。"角色 "是一种数据驱动的叙述工具,用于传达用户原型,捕捉个人的态度、目标和行为。本研究的目的是根据对 HAE 患者及其护理人员的访谈来创建和分析 "角色"。通过与患者、患者护理人员(患者和护理人员的双重角色)以及未受影响的护理人员进行人类学对话,进行了半结构化访谈。从定性和定量分析中获得的见解构成了创建角色的基础:我们招募了 17 名研究对象:结果:我们招募了 17 名研究对象:15 名患者(其中 6 名是患者护理人员)和 2 名非患者护理人员。参与者的平均年龄为 50.3 ± 14.4 岁。8名患者正在接受预防性治疗。HAE患者的血管性水肿生活质量(AE-QoL)平均百分比为(19.8 ± 12.0)分。我们确定了六个角色来描述参与者的个人病史、疾病管理和需求:四个角色指患者,一个指患者-护理者,一个指非患者-护理者。在患者角色中,表达最多的需求是心理支持和提高医护人员对疾病的认识。而护理人员则希望获得更多的疾病信息,包括最新的治疗方法,以及社区内更高的认知度:结论:基于角色的以人为本的创新方法超越了生理症状,涵盖了个人福祉的心理和社会方面,也将家庭纳入了评估范围。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases 医学-医学:研究与实验
CiteScore
6.30
自引率
8.10%
发文量
418
审稿时长
4-8 weeks
期刊介绍: Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信